Read the press release
Press release Guerbet - 30 May 2011
22/03/2011 Updated information about NSF and Dotarem
Information for Healthcare Professionals and other Stakeholders
05/01/2011 Price lowering Xenetix
Due to INAMI/RIZIV decision (reimbursement 12 y.) prices of the whole range of Xenetix have fallen by 15 % from January 01, 2011 in Belgium. See price list.
Due to name harmonization of the Guerbet affiliates, sa Codali nv becomes sa Guerbet nv from December 1st, 2010. Click on file for more information. letter FR letter NL
19/11/2010 T. Ishiguchi & Dotarem (Drugs RD 2010)
A study conducted on 3.444 patients during 4 year showed an excellent (99,53 %) global efficacy rate as well as a very good safety of Dotarem :
This study of 310 patients undergoing an assessment of the aorta and the abdominal vascular tree with 64 rows scanner, demonstrates the same diagnostic efficacy for Xenetix and Iomeron, with a lower concentration of iodine for Xenetix. The diagnostic efficacy was satisfactory to very...